Frank is the Founder and President of Ation Advisory Group where he is helping Global Life Science Companies to commercialize their product, service, or technology along with obtaining dilutive and non-dilutive funding. As a retired Pfizer Executive Frank worked for over 25 years in positions of increased responsibility in Finance, Strategy, & Operations. Frank lead the Supply Chain & Finance functions across 35 countries in Asia, Eastern Europe, Latin America (where he supported 9 countries), and the Middle East. Frank currently sits on the Area Board of The American Cancer Society. Frank holds a BS in Accounting from Providence College and an MBA in International Finance from NYU Stern School of Business.
Frank Orlowski, President & Founder at Ation Advisory Group
Newsletter
Get the Global Trial Accelerators™ newsletter
Practical insights on first-in-human and early feasibility trials across medtech, biotech/biopharma and radiopharma, in your inbox.
Free. Unsubscribe anytime. See the bioaccess® Privacy Policy (opens in a new tab) and the newsletter platform's Terms of Service (opens in a new tab).
Recent Episodes
- Varun Kalaiarasan, PhD Researcher at University of Cincinnati
- Ryan Beal, Chief Executive Officer at Dyve Biosciences
- Sandi Schaible, Founder & President at Bonded in Science
- Gennaro Maida, CEO and Founder at Denovo Innovations Group
- Benjamin Holmes, Chief Executive Officer at Nanochon
- Allison Komiyama, CEO and Founder at Bluestocking Health, LLC
- Daniel Zequeto, Founder & CEO at ODC Life Sciences
- Satabhisa Mukhopadhyay, Founder & Chief Scientist at 4D Path Inc
- Deborah Morley, Director CV Strategy and Delivery at RQM+
- See all →